Chemesis International Inc.
Chemesis International Inc. CADMF Peers
See (CADMF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CADMF | $0.08 | -16.67% | 0 | -0.29 | -$0.26 | N/A |
| MKGAF | $134.76 | +0.04% | 58.6B | 18.09 | $7.45 | +1.86% |
| MKKGY | $26.08 | -1.75% | 56.1B | 17.50 | $1.49 | +1.92% |
| TKPHF | $28.35 | +0.00% | 44.6B | 61.63 | $0.46 | +4.69% |
| HLNCF | $4.93 | -5.74% | 44.3B | 22.41 | $0.22 | +1.24% |
| IPSEY | $30.01 | +0.00% | 39.7B | 24.01 | $1.25 | +0.86% |
| SDZNY | $54.06 | +0.22% | 23.3B | -2703.00 | -$0.02 | +1.25% |
| TEVJF | $17.80 | +0.00% | 20.4B | -15.48 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOF | $18.05 | +0.00% | 15.4B | 12.99 | $1.39 | +2.31% |
Stock Comparison
CADMF vs MKGAF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, MKGAF has a market cap of 58.6B. Regarding current trading prices, CADMF is priced at $0.08, while MKGAF trades at $134.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas MKGAF's P/E ratio is 18.09. In terms of profitability, CADMF's ROE is N/A, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CADMF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs MKKGY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, MKKGY has a market cap of 56.1B. Regarding current trading prices, CADMF is priced at $0.08, while MKKGY trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas MKKGY's P/E ratio is 17.50. In terms of profitability, CADMF's ROE is N/A, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CADMF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs TKPHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, CADMF is priced at $0.08, while TKPHF trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas TKPHF's P/E ratio is 61.63. In terms of profitability, CADMF's ROE is N/A, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, CADMF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs HLNCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HLNCF has a market cap of 44.3B. Regarding current trading prices, CADMF is priced at $0.08, while HLNCF trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HLNCF's P/E ratio is 22.41. In terms of profitability, CADMF's ROE is N/A, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CADMF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs IPSEY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, IPSEY has a market cap of 39.7B. Regarding current trading prices, CADMF is priced at $0.08, while IPSEY trades at $30.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas IPSEY's P/E ratio is 24.01. In terms of profitability, CADMF's ROE is N/A, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, CADMF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SDZNY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SDZNY has a market cap of 23.3B. Regarding current trading prices, CADMF is priced at $0.08, while SDZNY trades at $54.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SDZNY's P/E ratio is -2703.00. In terms of profitability, CADMF's ROE is N/A, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, CADMF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs TEVJF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, CADMF is priced at $0.08, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, CADMF's ROE is N/A, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, CADMF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs ESALY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, CADMF is priced at $0.08, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CADMF's ROE is N/A, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CADMF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SGIOF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SGIOF has a market cap of 15.4B. Regarding current trading prices, CADMF is priced at $0.08, while SGIOF trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SGIOF's P/E ratio is 12.99. In terms of profitability, CADMF's ROE is N/A, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, CADMF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SGIOY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, CADMF is priced at $0.08, while SGIOY trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SGIOY's P/E ratio is 12.48. In terms of profitability, CADMF's ROE is N/A, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, CADMF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs BIOVF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, CADMF is priced at $0.08, while BIOVF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas BIOVF's P/E ratio is 24.17. In terms of profitability, CADMF's ROE is N/A, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, CADMF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs IPSEF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, CADMF is priced at $0.08, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas IPSEF's P/E ratio is 22.40. In terms of profitability, CADMF's ROE is N/A, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, CADMF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs ESALF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, ESALF has a market cap of 8.3B. Regarding current trading prices, CADMF is priced at $0.08, while ESALF trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas ESALF's P/E ratio is 26.17. In terms of profitability, CADMF's ROE is N/A, compared to ESALF's ROE of +0.03%. Regarding short-term risk, CADMF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SFOSF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SFOSF has a market cap of 8.2B. Regarding current trading prices, CADMF is priced at $0.08, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, CADMF's ROE is N/A, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, CADMF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs ESAIY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, ESAIY has a market cap of 8B. Regarding current trading prices, CADMF is priced at $0.08, while ESAIY trades at $7.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas ESAIY's P/E ratio is 25.32. In terms of profitability, CADMF's ROE is N/A, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, CADMF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs HKMPF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, CADMF is priced at $0.08, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, CADMF's ROE is N/A, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CADMF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs HKMPY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HKMPY has a market cap of 6B. Regarding current trading prices, CADMF is priced at $0.08, while HKMPY trades at $54.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HKMPY's P/E ratio is 16.91. In terms of profitability, CADMF's ROE is N/A, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CADMF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs GZPHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, GZPHF has a market cap of 5.7B. Regarding current trading prices, CADMF is priced at $0.08, while GZPHF trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas GZPHF's P/E ratio is 9.70. In terms of profitability, CADMF's ROE is N/A, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, CADMF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SGFEF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, CADMF is priced at $0.08, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SGFEF's P/E ratio is 25.35. In terms of profitability, CADMF's ROE is N/A, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, CADMF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs WIBFF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, CADMF is priced at $0.08, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, CADMF's ROE is N/A, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, CADMF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs HLBBF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, CADMF is priced at $0.08, while HLBBF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HLBBF's P/E ratio is 11.54. In terms of profitability, CADMF's ROE is N/A, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, CADMF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs LVZPF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, LVZPF has a market cap of 3.8B. Regarding current trading prices, CADMF is priced at $0.08, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, CADMF's ROE is N/A, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CADMF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs HLUBF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HLUBF has a market cap of 3.6B. Regarding current trading prices, CADMF is priced at $0.08, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HLUBF's P/E ratio is 7.12. In terms of profitability, CADMF's ROE is N/A, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, CADMF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs ULIHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, CADMF is priced at $0.08, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, CADMF's ROE is N/A, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, CADMF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs APNHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, CADMF is priced at $0.08, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas APNHF's P/E ratio is 12.95. In terms of profitability, CADMF's ROE is N/A, compared to APNHF's ROE of +0.04%. Regarding short-term risk, CADMF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs HYPMY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HYPMY has a market cap of 3.2B. Regarding current trading prices, CADMF is priced at $0.08, while HYPMY trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HYPMY's P/E ratio is 21.85. In terms of profitability, CADMF's ROE is N/A, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, CADMF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs APNHY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, APNHY has a market cap of 3.1B. Regarding current trading prices, CADMF is priced at $0.08, while APNHY trades at $6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas APNHY's P/E ratio is 12.48. In terms of profitability, CADMF's ROE is N/A, compared to APNHY's ROE of +0.05%. Regarding short-term risk, CADMF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs INVVY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, CADMF is priced at $0.08, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CADMF's ROE is N/A, compared to INVVY's ROE of -0.01%. Regarding short-term risk, CADMF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs IZQVF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, CADMF is priced at $0.08, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CADMF's ROE is N/A, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, CADMF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs LBTSF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, CADMF is priced at $0.08, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas LBTSF's P/E ratio is 95.43. In terms of profitability, CADMF's ROE is N/A, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, CADMF is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs HMDCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, CADMF is priced at $0.08, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, CADMF's ROE is N/A, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, CADMF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs DNPUF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, CADMF is priced at $0.08, while DNPUF trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas DNPUF's P/E ratio is 15.85. In terms of profitability, CADMF's ROE is N/A, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, CADMF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SMDPY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SMDPY has a market cap of 2.4B. Regarding current trading prices, CADMF is priced at $0.08, while SMDPY trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SMDPY's P/E ratio is 14.83. In terms of profitability, CADMF's ROE is N/A, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, CADMF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs THCBF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, CADMF is priced at $0.08, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas THCBF's P/E ratio is -0.10. In terms of profitability, CADMF's ROE is N/A, compared to THCBF's ROE of +0.00%. Regarding short-term risk, CADMF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs CHSYF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, CADMF is priced at $0.08, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, CADMF's ROE is N/A, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, CADMF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs DMPHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, CADMF is priced at $0.08, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, CADMF's ROE is N/A, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, CADMF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs HTSUF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, CADMF is priced at $0.08, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HTSUF's P/E ratio is 14.19. In terms of profitability, CADMF's ROE is N/A, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, CADMF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs LJUIF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, CADMF is priced at $0.08, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, CADMF's ROE is N/A, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, CADMF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs ARSUF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, CADMF is priced at $0.08, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, CADMF's ROE is N/A, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, CADMF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs TSMRF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, CADMF is priced at $0.08, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas TSMRF's P/E ratio is 8.05. In terms of profitability, CADMF's ROE is N/A, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, CADMF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs NPNKF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, CADMF is priced at $0.08, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas NPNKF's P/E ratio is 7.61. In terms of profitability, CADMF's ROE is N/A, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, CADMF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs YIHCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, YIHCF has a market cap of 1.7B. Regarding current trading prices, CADMF is priced at $0.08, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CADMF's ROE is N/A, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, CADMF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs MITPF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, CADMF is priced at $0.08, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas MITPF's P/E ratio is -10.81. In terms of profitability, CADMF's ROE is N/A, compared to MITPF's ROE of +4.92%. Regarding short-term risk, CADMF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs CHIZF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CHIZF has a market cap of 1.6B. Regarding current trading prices, CADMF is priced at $0.08, while CHIZF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CHIZF's P/E ratio is 15.63. In terms of profitability, CADMF's ROE is N/A, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, CADMF is less volatile compared to CHIZF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs KARBF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, CADMF is priced at $0.08, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CADMF's ROE is N/A, compared to KARBF's ROE of N/A. Regarding short-term risk, CADMF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SHEZF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SHEZF has a market cap of 1.5B. Regarding current trading prices, CADMF is priced at $0.08, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CADMF's ROE is N/A, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, CADMF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs EVOTF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, CADMF is priced at $0.08, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, CADMF's ROE is N/A, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, CADMF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs NPPNY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, NPPNY has a market cap of 1.5B. Regarding current trading prices, CADMF is priced at $0.08, while NPPNY trades at $5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas NPPNY's P/E ratio is 6.53. In terms of profitability, CADMF's ROE is N/A, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, CADMF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs GTBIF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, GTBIF has a market cap of 1.3B. Regarding current trading prices, CADMF is priced at $0.08, while GTBIF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas GTBIF's P/E ratio is 26.19. In terms of profitability, CADMF's ROE is N/A, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, CADMF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs KSPHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, CADMF is priced at $0.08, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas KSPHF's P/E ratio is 14.51. In terms of profitability, CADMF's ROE is N/A, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, CADMF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs SWGHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, CADMF is priced at $0.08, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, CADMF's ROE is N/A, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, CADMF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs GNMLF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, CADMF is priced at $0.08, while GNMLF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas GNMLF's P/E ratio is 9.33. In terms of profitability, CADMF's ROE is N/A, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, CADMF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs KKPCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, CADMF is priced at $0.08, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas KKPCF's P/E ratio is 11.02. In terms of profitability, CADMF's ROE is N/A, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, CADMF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs CASBF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CASBF has a market cap of 985.3M. Regarding current trading prices, CADMF is priced at $0.08, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CASBF's P/E ratio is -15.24. In terms of profitability, CADMF's ROE is N/A, compared to CASBF's ROE of -0.14%. Regarding short-term risk, CADMF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs BIOGY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, BIOGY has a market cap of 934M. Regarding current trading prices, CADMF is priced at $0.08, while BIOGY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas BIOGY's P/E ratio is 29.63. In terms of profitability, CADMF's ROE is N/A, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, CADMF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SHPHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, CADMF is priced at $0.08, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, CADMF's ROE is N/A, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, CADMF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs EVRRF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, EVRRF has a market cap of 895.3M. Regarding current trading prices, CADMF is priced at $0.08, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, CADMF's ROE is N/A, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, CADMF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs LVTTF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, LVTTF has a market cap of 894.1M. Regarding current trading prices, CADMF is priced at $0.08, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, CADMF's ROE is N/A, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, CADMF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs NRXCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, NRXCF has a market cap of 849.5M. Regarding current trading prices, CADMF is priced at $0.08, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, CADMF's ROE is N/A, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, CADMF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs TWAPF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, CADMF is priced at $0.08, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas TWAPF's P/E ratio is 6.37. In terms of profitability, CADMF's ROE is N/A, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, CADMF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs CSWYF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, CADMF is priced at $0.08, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, CADMF's ROE is N/A, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, CADMF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs TCNNF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, TCNNF has a market cap of 737.5M. Regarding current trading prices, CADMF is priced at $0.08, while TCNNF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas TCNNF's P/E ratio is -4.89. In terms of profitability, CADMF's ROE is N/A, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, CADMF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs NIKA Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, CADMF is priced at $0.08, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas NIKA's P/E ratio is N/A. In terms of profitability, CADMF's ROE is N/A, compared to NIKA's ROE of +0.39%. Regarding short-term risk, CADMF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs TRXPF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, CADMF is priced at $0.08, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CADMF's ROE is N/A, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CADMF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs SWDCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, SWDCF has a market cap of 655.3M. Regarding current trading prices, CADMF is priced at $0.08, while SWDCF trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas SWDCF's P/E ratio is 68.33. In terms of profitability, CADMF's ROE is N/A, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CADMF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs ELTP Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, ELTP has a market cap of 641.1M. Regarding current trading prices, CADMF is priced at $0.08, while ELTP trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas ELTP's P/E ratio is -30.00. In terms of profitability, CADMF's ROE is N/A, compared to ELTP's ROE of -0.36%. Regarding short-term risk, CADMF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs CURLF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CURLF has a market cap of 632.4M. Regarding current trading prices, CADMF is priced at $0.08, while CURLF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CURLF's P/E ratio is -2.53. In terms of profitability, CADMF's ROE is N/A, compared to CURLF's ROE of -0.25%. Regarding short-term risk, CADMF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs TRSSF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, CADMF is priced at $0.08, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CADMF's ROE is N/A, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, CADMF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs PKBFF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, PKBFF has a market cap of 551.5M. Regarding current trading prices, CADMF is priced at $0.08, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas PKBFF's P/E ratio is N/A. In terms of profitability, CADMF's ROE is N/A, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CADMF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs CCHWF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, CADMF is priced at $0.08, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CADMF's ROE is N/A, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, CADMF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs GLASF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, GLASF has a market cap of 499.1M. Regarding current trading prices, CADMF is priced at $0.08, while GLASF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas GLASF's P/E ratio is -78.56. In terms of profitability, CADMF's ROE is N/A, compared to GLASF's ROE of +0.00%. Regarding short-term risk, CADMF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs BOIRF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, CADMF is priced at $0.08, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, CADMF's ROE is N/A, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, CADMF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs PEXXF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, CADMF is priced at $0.08, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CADMF's ROE is N/A, compared to PEXXF's ROE of N/A. Regarding short-term risk, CADMF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs KHTRF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, KHTRF has a market cap of 437.4M. Regarding current trading prices, CADMF is priced at $0.08, while KHTRF trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas KHTRF's P/E ratio is 62.71. In terms of profitability, CADMF's ROE is N/A, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, CADMF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs AGYTF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, CADMF is priced at $0.08, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, CADMF's ROE is N/A, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, CADMF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs HUMDF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, CADMF is priced at $0.08, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, CADMF's ROE is N/A, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, CADMF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs AIHLF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, AIHLF has a market cap of 396.2M. Regarding current trading prices, CADMF is priced at $0.08, while AIHLF trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas AIHLF's P/E ratio is 8.45. In terms of profitability, CADMF's ROE is N/A, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CADMF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs BHCCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, CADMF is priced at $0.08, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CADMF's ROE is N/A, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, CADMF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs CPHRF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CPHRF has a market cap of 246.2M. Regarding current trading prices, CADMF is priced at $0.08, while CPHRF trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CPHRF's P/E ratio is 26.69. In terms of profitability, CADMF's ROE is N/A, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, CADMF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs PLNHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, CADMF is priced at $0.08, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CADMF's ROE is N/A, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, CADMF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs VRNOF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, VRNOF has a market cap of 176.3M. Regarding current trading prices, CADMF is priced at $0.08, while VRNOF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas VRNOF's P/E ratio is -0.49. In terms of profitability, CADMF's ROE is N/A, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, CADMF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs CRLBF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CRLBF has a market cap of 169M. Regarding current trading prices, CADMF is priced at $0.08, while CRLBF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CRLBF's P/E ratio is -2.08. In terms of profitability, CADMF's ROE is N/A, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, CADMF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs PHCUF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, PHCUF has a market cap of 137.2M. Regarding current trading prices, CADMF is priced at $0.08, while PHCUF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas PHCUF's P/E ratio is 515.00. In terms of profitability, CADMF's ROE is N/A, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, CADMF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs COPHF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, CADMF is priced at $0.08, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CADMF's ROE is N/A, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CADMF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs STMH Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, STMH has a market cap of 126.7M. Regarding current trading prices, CADMF is priced at $0.08, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas STMH's P/E ratio is N/A. In terms of profitability, CADMF's ROE is N/A, compared to STMH's ROE of -2.75%. Regarding short-term risk, CADMF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs NWPN Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, CADMF is priced at $0.08, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas NWPN's P/E ratio is -0.04. In terms of profitability, CADMF's ROE is N/A, compared to NWPN's ROE of +0.13%. Regarding short-term risk, CADMF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs CBWTF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CBWTF has a market cap of 120.7M. Regarding current trading prices, CADMF is priced at $0.08, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CBWTF's P/E ratio is 4.58. In terms of profitability, CADMF's ROE is N/A, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, CADMF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs CHALF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CHALF has a market cap of 116.3M. Regarding current trading prices, CADMF is priced at $0.08, while CHALF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CHALF's P/E ratio is N/A. In terms of profitability, CADMF's ROE is N/A, compared to CHALF's ROE of +0.00%. Regarding short-term risk, CADMF is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs HLTRF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, HLTRF has a market cap of 115.5M. Regarding current trading prices, CADMF is priced at $0.08, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, CADMF's ROE is N/A, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, CADMF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs LPCUF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, CADMF is priced at $0.08, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, CADMF's ROE is N/A, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, CADMF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs CNVCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, CADMF is priced at $0.08, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CADMF's ROE is N/A, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, CADMF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs LOVFF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, LOVFF has a market cap of 99.7M. Regarding current trading prices, CADMF is priced at $0.08, while LOVFF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas LOVFF's P/E ratio is 10.90. In terms of profitability, CADMF's ROE is N/A, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, CADMF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs BIOYF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, BIOYF has a market cap of 99M. Regarding current trading prices, CADMF is priced at $0.08, while BIOYF trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas BIOYF's P/E ratio is 17.61. In terms of profitability, CADMF's ROE is N/A, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, CADMF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs GRUSF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, GRUSF has a market cap of 90.7M. Regarding current trading prices, CADMF is priced at $0.08, while GRUSF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas GRUSF's P/E ratio is -12.20. In terms of profitability, CADMF's ROE is N/A, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, CADMF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs LRDSF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, CADMF is priced at $0.08, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, CADMF's ROE is N/A, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, CADMF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs GBLP Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, CADMF is priced at $0.08, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas GBLP's P/E ratio is -0.67. In terms of profitability, CADMF's ROE is N/A, compared to GBLP's ROE of +0.31%. Regarding short-term risk, CADMF is more volatile compared to GBLP. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs DUTV Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, DUTV has a market cap of 76.3M. Regarding current trading prices, CADMF is priced at $0.08, while DUTV trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas DUTV's P/E ratio is N/A. In terms of profitability, CADMF's ROE is N/A, compared to DUTV's ROE of +0.02%. Regarding short-term risk, CADMF is more volatile compared to DUTV. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.
CADMF vs ABSCF Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, ABSCF has a market cap of 74.8M. Regarding current trading prices, CADMF is priced at $0.08, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, CADMF's ROE is N/A, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, CADMF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for CADMF.
CADMF vs EOFBY Comparison
CADMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CADMF stands at 0. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, CADMF is priced at $0.08, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CADMF currently has a P/E ratio of -0.29, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, CADMF's ROE is N/A, compared to EOFBY's ROE of N/A. Regarding short-term risk, CADMF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for CADMF.